- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00582374
Periodontal Disease and Preterm Birth
March 24, 2017 updated by: University of Oklahoma
Periodontal Disease, Inflammatory Markers, and Preterm Birth
To determine the relationship between periodontal disease and upper genital tract inflammation in pregnancy.
To determine whether certain fluid levels in the oral cavity and the vagina are associated with preterm birth or low-birth weight.
Study Overview
Status
Withdrawn
Conditions
Detailed Description
Patients will be enrolled in the study at their first prenatal visit after the details of the study have been discussed.
Potential subjects will be presented with a questionnaire to determine eligibility for the study.
The patient will be scheduled for an exam between 18-24 weeks at which time they will undergo a periodontal assessment, to determine the presence or absence of periodontal disease, a sampling of gingival crevicular fluid (GCF) and a vaginal swab collection.
Periodontal disease will be determined by measuring the depth of gingival sulci, amount of periodontal attachment loss, and prevalence of gingival bleeding at six sites for each tooth present.
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma Health Sciences Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 35 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Pregnant women from the OU Medical Center Women's Clinic
Description
Inclusion Criteria:
- Between the ages of 15-35
- Singleton gestation
Exclusion Criteria:
- Diabetes prior to pregnancy
- Require antibiotic prophylaxis prior to dental treatment
- Require steroids during pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
A
Pregnant Women
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To determine the relationship between periodontal disease and upper genital tract inflammation as measured by cytokine levels IL-6, IL-1, and TNF-α and MMP levels from the posterior fornix of the vagina.
Time Frame: 4 years
|
4 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To determine whether IL-1β levels in the oral cavity and the vagina are associated with preterm birth or low-birth weight.
Time Frame: 4 years
|
4 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eric Knudtson, MD, University of Oklahoma
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2005
Primary Completion (Anticipated)
March 1, 2009
Study Completion (Anticipated)
March 1, 2009
Study Registration Dates
First Submitted
December 19, 2007
First Submitted That Met QC Criteria
December 27, 2007
First Posted (Estimate)
December 28, 2007
Study Record Updates
Last Update Posted (Actual)
March 28, 2017
Last Update Submitted That Met QC Criteria
March 24, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PeriodontalPreTermBirth
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.